anmelden
SMI Expanded
1.969,60
PKT
+3,21
PKT
+0,16
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.02.17 | Swiss Re Sell | UBS AG | |
| 01.02.17 | Givaudan Hold | Deutsche Bank AG | |
| 01.02.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.02.17 | Givaudan Sell | Citigroup Corp. | |
| 01.02.17 | Holcim overweight | Morgan Stanley | |
| 01.02.17 | Holcim kaufen | HSBC | |
| 31.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 31.01.17 | UBS Underperform | BNP PARIBAS | |
| 31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.17 | UBS overweight | Barclays Capital | |
| 30.01.17 | UBS overweight | Morgan Stanley | |
| 30.01.17 | UBS Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | UBS AG | |
| 30.01.17 | Novartis buy | HSBC | |
| 30.01.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 27.01.17 | UBS Outperform | BMO Capital Markets | |
| 27.01.17 | UBS buy | Citigroup Corp. | |
| 27.01.17 | UBS buy | Citigroup Corp. | |
| 27.01.17 | UBS Neutral | Credit Suisse Group | |
| 27.01.17 | UBS Outperform | RBC Capital Markets | |
| 27.01.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 27.01.17 | UBS overweight | Barclays Capital | |
| 27.01.17 | UBS buy | S&P Capital IQ | |
| 27.01.17 | UBS buy | Baader Bank | |
| 27.01.17 | UBS Hold | Commerzbank AG | |
| 26.01.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 26.01.17 | Novartis Underweight | Morgan Stanley | |
| 26.01.17 | Novartis Hold | Deutsche Bank AG | |
| 26.01.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.01.17 | UBS buy | Goldman Sachs Group Inc. | |
| 25.01.17 | UBS Buy | UBS AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 25.01.17 | UBS Hold | Deutsche Bank AG | |
| 25.01.17 | UBS Hold | Deutsche Bank AG | |
| 25.01.17 | Nestlé buy | UBS AG | |
| 25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Zurich Insurance Outperform | BNP PARIBAS |
